Cancer incidence and mortality projections in the UK until 2035

Abstract

Background:Cancer incidence and mortality projections are important for understanding the evolving landscape for cancer risk factors as well as anticipating future burden on the health service.Methods:We used an age–period–cohort model with natural cubic splines to estimate cancer cases and deaths from 2015 to 2035 based on 1979–2014 UK data. This was converted to rates using ONS population projections. Modified data sets were generated for breast and prostate cancers.Results:Cancer incidence rates are projected to decrease by 0.03% in males and increase by 0.11% in females yearly between 2015 and 2035; thyroid, liver, oral and kidney cancer are among the fastest accelerating cancers. 243 690 female and 270 261 male cancer cases are projected for 2035. Breast and prostate cancers are projected to be the most common cancers among females and males, respectively in 2035. Most cancers' mortality rate is decreasing; there are notable increases for liver, oral and anal cancer. For 2035, there are 95 961 female deaths projected and 116 585 male deaths projected.Conclusions:These findings stress the need to continue efforts to address cancer risk factors. Furthermore, the increased burden of the number of cancer cases and deaths as a result of the growing and ageing population should be taken into consideration by healthcare planners.

Statin use and risk of liver cancer: Evidence from two population‐based studies

“…Major risk factors for liver cancer include hepatitis C virus (HCV) infection, hepatitis B virus (HBV) infection, heavy alcohol drinking and nonalcoholic fatty liver disease (NAFLD) . With further increases in liver cancer incidence predicted, there is growing interest in identifying modifiable risk factors for liver cancer, especially those that can be targeted with medications, such as aspirin and nonsteroidal antiinflammatory drugs (NSAIDs). Use of statins (or 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase inhibitors), commonly used because of their efficacy in preventing cardiovascular morbidity and mortality, has been shown to be inversely related to risk of various cancers …”

Investigating the role of psychological flexibility, masculine self‐esteem and stoicism as predictors of psychological distress and quality of life in men living with prostate cancer

“…Over 1 million men are diagnosed with prostate cancer worldwide each year (International Agency for Research on Cancer, ). In the UK, incidence rates have increased dramatically in the past 25 years and are projected to increase a further 12% by 2035 (Smittenaar, Petersen, Stewart, & Moitt, ). Survival rates have also increased markedly over recent years, with over 90% of patients estimated to survive at least 5 years after diagnosis ( & England, 2).…”

Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based study

“…Lung cancer is the leading cause of cancer death in the UK for both men and women: in 2014, >19 000 deaths were observed in men and >16 000 in women, corresponding to age-standardised mortality rates of 89.69 and 60.52 per 100 000 person-years, respectively 1. Despite encouraging decreasing age-standardised incidence in lung cancer,1 it remains a major public health issue given its poor prognosis; for patients diagnosed in England between 2010 and 2014, the 1-year age-standardised net survival probability was estimated at 34% in men and 40% in women, those figures being 11% and 16% at 5 years 2…”

“…Despite encouraging decreasing age-standardised incidence in lung cancer,1 it remains a major public health issue given its poor prognosis; for patients diagnosed in England between 2010 and 2014, the 1-year age-standardised net survival probability was estimated at 34% in men and 40% in women, those figures being 11% and 16% at 5 years 2…”